Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease - Wikidata - awgldk - TriplyDB

Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease

Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease

http://www.wikidata.org/entity/Q27010136

about

Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome.Serum salusin-α levels are inversely correlated with the presence and severity of coronary artery disease.Insulin resistance and adipokine levels correlate with early atherosclerosis - a study in prediabetic patients.Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.

P2860

Q35009634-C69C8CF6-AAF8-4B55-A07F-888B220D1BAE Q35043344-6D35E052-F876-427E-8F99-0FE222D45DFC Q38163997-43C5DB85-004B-4107-94DB-D08558E99616 Q47748962-0EA64413-AD43-4D43-AA8D-EB911F48DB2B Q51049759-3A566C1C-A794-4458-BF2D-53A62C5307E1 Q51315349-6731657F-9EE2-4DF9-928F-21832D5EF77F Q54569586-C524759B-5D85-4B7C-B32F-40EF08954388

P2860

Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease

http://www.wikidata.org/entity/Q27010136

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Endogenous bioactive peptides ...... lerotic coronary heart disease

@ast

Endogenous bioactive peptides ...... lerotic coronary heart disease

@en

Endogenous bioactive peptides ...... lerotic coronary heart disease

@nl

type

label

Endogenous bioactive peptides ...... lerotic coronary heart disease

@ast

Endogenous bioactive peptides ...... lerotic coronary heart disease

@en

Endogenous bioactive peptides ...... lerotic coronary heart disease

@nl

prefLabel

Endogenous bioactive peptides ...... lerotic coronary heart disease

@ast

Endogenous bioactive peptides ...... lerotic coronary heart disease

@en

Endogenous bioactive peptides ...... lerotic coronary heart disease

@nl

P1433

Q27010136-24883A92-2F3D-4A21-B20E-84F795E0A717

P1476

Q27010136-020E5345-B843-4FB6-A585-FAB9A465DEE8

P2093

Q27010136-7565364F-F20E-45E1-8072-6F4EC43809F6

Q27010136-8B275B3F-2C33-43D0-A523-9B728781E340

Q27010136-D7B9F433-84F8-444E-A34E-7688DE2EEFE8

Q27010136-FC33AAD5-559E-42C6-B1BC-FDCECC3A27FE

P275

Q27010136-B17F68D2-BF01-423D-868D-F9FB4EC10EFE

P2860

Q27010136-006CC81D-0FD0-40A1-B35B-5A3896500DC0

Q27010136-03B67DE6-9E43-4453-98BC-DDCCD9917AD9

Q27010136-0521FBC9-5F77-40D7-A9F2-F30497CC0DC7

Q27010136-05513AAC-74DF-4F53-8C7B-48E6A467BA9A

Q27010136-0826C613-826C-4E19-A47B-15E157EAE018

Q27010136-0BA085CF-1A5C-458C-B26C-66700347FC69

Q27010136-0CE66D98-923D-42C8-820E-ED1BA2460637

Q27010136-0D386A6F-4628-4C53-8ECF-27FFC680FDE6

Q27010136-140453AB-9473-434A-84F4-8A617A15B824

Q27010136-164AAC85-21E0-4146-A93F-AAA2086708E8

P304

Q27010136-57E6D8DC-9C99-4E45-869C-075149BF5AFD

P31

Q27010136-7DCA8D54-67C1-4077-9ABE-8CAF0CB249C8

P356

Q27010136-FB783710-79D1-4B9B-9950-AD80AD4A00D2

P407

Q27010136-DCB9BAB5-EBF3-4092-9D38-FAC973DEF81C

P433

Q27010136-707CFBA6-67AF-4157-900F-077ED19A94F0

P478

Q27010136-A0F7623A-CFF0-4D1B-8BE7-E7642D652242

P50

Q27010136-9D25E60B-2693-434A-B138-2A8B1AF96473

Q27010136-CE341EE3-6875-4EB7-AC1C-A044DE5C9167

P5008

Q27010136-5753554F-B31A-42DF-88F0-577D05708964

P577

Q27010136-7239A565-FB88-4E17-AA3E-E73CAC95FEB5

P5875

Q27010136-6124D1E2-3909-41E9-82E3-7E88A2BD2E61

P698

Q27010136-B0996EAA-516B-4E77-A9E3-C8C6F4A6784B

P921

Q27010136-412D26C3-5F43-463B-BFDA-9370A1F357F0

Q27010136-48CA4B7F-E4F3-4672-92CE-C039ED3AB005

Q27010136-6FCA9021-DA91-4BB2-9D04-4CD962B4329D

Q27010136-E37BF39C-FBFE-486F-B0BD-F0AF4EE9D0FC

P932

Q27010136-7B1C0179-9700-49AA-9938-110BB95AB7E3

P356

P1433

P1476

Endogenous bioactive peptides ...... lerotic coronary heart disease

@en

P2093

Fumiko Itoh

http://www.w3.org/2001/XMLSchema#string

Kengo Sato

http://www.w3.org/2001/XMLSchema#string

Takuya Watanabe

http://www.w3.org/2001/XMLSchema#string

Tsutomu Hirano

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages

Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities

Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

Presence of immunoreactive salusin-alpha in human serum and urine.

Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques

Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis

The biology of incretin hormones.

Role of biomarkers in risk stratification of acute coronary syndrome

P304

4974-4985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/S120404974

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Masayoshi Shichiri

Kohei Wakabayashi

P5008

P577

2012-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225186961

http://www.w3.org/2001/XMLSchema#string

P698

22666071

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

coronary artery disease

P932

3355454

http://www.w3.org/2001/XMLSchema#string